FDA Adverse Event Malfunction Summary report: N

ELECSYS IGE II IMMUNOASSAY

MDR report key: 6604794 · Received June 1, 2017

Report

Report Number
1823260-2017-01123
Event Type
Malfunction
Date Received
June 1, 2017
Date of Event
May 10, 2017
Report Date
August 17, 2017
Manufacturer
ROCHE DIAGNOSTICS
Product Code
JHR
PMA / PMN Number
K061970
Removal / Correction Number
NA
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
PO
Reporter Occupation
HEALTH PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

SAMPLE FROM THE PATIENT WAS SUBMITTED FOR INVESTIGATION AND AN INCREASED LEVEL OF IGE-IGG COMPLEXES WAS DETECTED. THIS MOST LIKELY CAUSED THE REDUCED DETECTION OF IGE IN THE UNDILUTED SAMPLE. THESE COMPLEXES MAY RESULT FROM AN AUTO-IMMUNE DISEASE AND/OR MAY BE REMNANTS OF A TERMINATED ANTI-ALLERGY OR ANTI-ASTHMA THERAPY. PRODUCT LABELING FOR THE ASSAY STATES NOT TO USE THE ASSAY FOR PATIENTS UNDER TREATMENT WITH XOLAIR OR SIMILAR DRUGS CONTAINING ANTI-IGE ANTIBODIES.

Additional Manufacturer Narrative · 1

(B)(4). THIS EVENT OCCURRED IN (B)(6).

Description of Event or Problem · 1

THE CUSTOMER RECEIVED A QUESTIONABLE ELECSYS IGE II IMMUNOASSAY RESULT FOR ONE PATIENT SAMPLE. THE CUSTOMER USED COBAS 8000 E 602 MODULE SERIAL NUMBER (B)(4). THE INITIAL RESULT FOR THIS SAMPLE WAS 991.7 IU/ML. THE DOCTOR DID NOT AGREE WITH THE RESULT AS IT WAS NOT CONSISTENT WITH THE MEDICAL HISTORY. THIS PATIENT NORMALLY HAD A RESULT OF 21000 UI/ML. THE CUSTOMER PERFORMED DILUTIONS OF THE SAMPLE AS FOLLOWS: 1:5 DILUTION RESULT WAS 4569 IU/ML. A 1:10 DILUTION RESULT WAS 12609 IU/ML. A 1:50 DILUTION RESULT WAS 20333 IU/ML. A 1:100 DILUTION RESULT WAS 21548 IU/ML. THERE WAS NO ALLEGATION OF AN ADVERSE EVENT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
385379 ELECSYS IGE II IMMUNOASSAY RADIOIMMUNOASSAY, IMMUNOGLOBULINS (D,E) JHR ROCHE DIAGNOSTICS IGE 17305400

Patients

Seq Age Sex Outcome Treatment
1 19 YR